PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NTLA vs. SE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NTLA and SE is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

NTLA vs. SE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intellia Therapeutics, Inc. (NTLA) and Sea Limited (SE). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
-49.71%
46.70%
NTLA
SE

Key characteristics

Sharpe Ratio

NTLA:

-0.96

SE:

5.45

Sortino Ratio

NTLA:

-1.49

SE:

5.80

Omega Ratio

NTLA:

0.83

SE:

1.71

Calmar Ratio

NTLA:

-0.63

SE:

2.38

Martin Ratio

NTLA:

-1.77

SE:

34.62

Ulcer Index

NTLA:

33.25%

SE:

6.21%

Daily Std Dev

NTLA:

61.60%

SE:

39.47%

Max Drawdown

NTLA:

-93.20%

SE:

-90.51%

Current Drawdown

NTLA:

-93.11%

SE:

-69.85%

Fundamentals

Market Cap

NTLA:

$1.34B

SE:

$66.50B

EPS

NTLA:

-$5.45

SE:

$0.15

PEG Ratio

NTLA:

-0.10

SE:

0.62

Total Revenue (TTM)

NTLA:

$43.09M

SE:

$15.49B

Gross Profit (TTM)

NTLA:

$35.51M

SE:

$6.53B

EBITDA (TTM)

NTLA:

-$527.52M

SE:

$701.01M

Returns By Period

In the year-to-date period, NTLA achieves a -60.05% return, which is significantly lower than SE's 173.19% return.


NTLA

YTD

-60.05%

1M

-7.16%

6M

-49.71%

1Y

-59.67%

5Y*

-4.68%

10Y*

N/A

SE

YTD

173.19%

1M

-3.34%

6M

46.70%

1Y

191.39%

5Y*

23.22%

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NTLA vs. SE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Intellia Therapeutics, Inc. (NTLA) and Sea Limited (SE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NTLA, currently valued at -0.96, compared to the broader market-4.00-2.000.002.00-0.965.45
The chart of Sortino ratio for NTLA, currently valued at -1.49, compared to the broader market-4.00-2.000.002.004.00-1.495.80
The chart of Omega ratio for NTLA, currently valued at 0.83, compared to the broader market0.501.001.502.000.831.71
The chart of Calmar ratio for NTLA, currently valued at -0.63, compared to the broader market0.002.004.006.00-0.632.38
The chart of Martin ratio for NTLA, currently valued at -1.77, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.7734.62
NTLA
SE

The current NTLA Sharpe Ratio is -0.96, which is lower than the SE Sharpe Ratio of 5.45. The chart below compares the historical Sharpe Ratios of NTLA and SE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-2.000.002.004.006.00JulyAugustSeptemberOctoberNovemberDecember
-0.96
5.45
NTLA
SE

Dividends

NTLA vs. SE - Dividend Comparison

Neither NTLA nor SE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NTLA vs. SE - Drawdown Comparison

The maximum NTLA drawdown since its inception was -93.20%, roughly equal to the maximum SE drawdown of -90.51%. Use the drawdown chart below to compare losses from any high point for NTLA and SE. For additional features, visit the drawdowns tool.


-90.00%-85.00%-80.00%-75.00%-70.00%JulyAugustSeptemberOctoberNovemberDecember
-93.11%
-69.85%
NTLA
SE

Volatility

NTLA vs. SE - Volatility Comparison

Intellia Therapeutics, Inc. (NTLA) has a higher volatility of 19.57% compared to Sea Limited (SE) at 8.59%. This indicates that NTLA's price experiences larger fluctuations and is considered to be riskier than SE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%JulyAugustSeptemberOctoberNovemberDecember
19.57%
8.59%
NTLA
SE

Financials

NTLA vs. SE - Financials Comparison

This section allows you to compare key financial metrics between Intellia Therapeutics, Inc. and Sea Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab